X’s Location Feature Stirs Uproar & Novo Nordisk Tanks After Failed Alzheimer’s Trial
Episode 721: Neal and Toby chat about X’s new location transparency feature that has opened up a can of worms as some of the most divisive accounts on US politics aren’t actually from the US. Then, Novo Nordisk has taken a big hit after its trials to develop a drug to delay Alzheimer’s have failed. Plus, the Trump…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Morning Brew Daily
See all episodes →
56%Meta Just Beat Apple at Its Own Game & McDonald’s Is Upgrading Restaurants
41%AI Leaders Agree to Slow Things Down & Tesla Makes a Surprising Comeback
McDonald's Sued for Alleged Price Fixing & LeBron's Polymarket Deal Is 4x His NBA Salary
Similar episodes from other shows
More like Morning Brew Daily →
Novo Nordisk hits back at copycat drugs
Justice Department Takes Aim At Alphabet… Plus A Sweet Tooth Deal Worth Billions 8/14/24
The AI Chart Everyone Is Getting Wrong
Starbucks’ Bold Move
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.